source-attributed worked case · reviewed 2026-08-11

Ritonavir and the path that seemed to disappear

Ritonavir stayed the same chemical compound. A different crystal arrangement changed which form became easy to obtain—and changed what the capsule could reliably do.

Historical education only. This is not medical advice, treatment advice, a present-day product assessment, or a manufacturing recipe.

A source-labelled map separating the unknown first Form-II nucleus, a tested possible trigger, later seeding, capsule-lot dissolution failure, and three later Form-I recovery routes. — A schematic reading aid. It is not a crystal structure and it gives no process instructions.

In plain words

A molecule can pack into more than one crystal structure without becoming a different chemical. Development work had found only the form later called Form I. In early 1998, capsule lots failed dissolution and investigators identified a previously unknown Form II. Under the cited conditions, Form II was more stable and substantially less soluble.

Once Form-II crystals existed, their surfaces could make later Form-II growth easier under suitable conditions. That did not prove what caused the first historical nucleus. The old route became hard to reproduce; the old form did not leave reality. Later controlled crystallization and milling studies produced Form I again.

Not observed is not impossible. Not reproduced is not permanently absent. A changed result can correct the map without changing the molecule.

Five levels that must stay separate

Science

Same molecule; different conformation and crystal packing.

Process

Conditions and crystal history changed which route was easy.

Product

Lower-solubility Form II precipitated; capsule lots failed dissolution.

Supply

Capsule production and supply were disrupted; regulators reviewed a replacement.

KINGDOM

Reality can reveal a reachable state that the working map omitted.

the honest unknown

The first historical nucleus remains unsettled

A related cyclic-carbamate degradant nucleated Form II in an experiment and was proposed as a possible trigger. That shows a plausible route; it does not prove the cause of the 1998 event. Stories about a particular person or object carrying crystals between sites are unsettled too.

The geometry, translated

Landscape: What the material could reach was larger than the forms found by one earlier search.
Barrier: A stable form could remain unseen while its first ordered nucleus was hard to make.
Seeded path: An existing crystal surface made one later route easier only under suitable conditions.
Return: Dissolution failure and later experiments returned evidence that corrected the working map.
Repair: New formulation and process acts were tested against the state now known to be reachable.

This is an attributed teaching analogy for systems architecture. No crystal mechanism is transferred to software, culture, or beings. Reading it records no choice and authorises no action.

Read the record, not just the story

The machine-readable case carries twelve attributed claims, their scopes and limits, two checked unknowns, one out-of-scope question, a timeline, ten source locators, and explicit claims not made. Its exact reviewed bytes are preserved at the first public commit.

The local guest case remains the factual home. This repository is its authoritative public mirror and immutable receipt; the page and drawing do not create another account.

Folding, prions, KARMA, and feedback Current JSON case Current SVG map Immutable JSON receipt Castle interpretation Correction path Published corrections Provenance Rights

Reviewed case SHA-256: 652a04699aadc6143d9136dc8d515fd3b4fa8774d963d885e79968156b1cb8ad

Matching these case bytes does not prove the external publications, the interpretation, causation, understanding, or present-day product behaviour. External source bytes are not bundled or checked at runtime. The linked Castle room is a separately correctable interpretation, not another scientific source.

Source anchors

Chemburkar et al. (2000) — process account and controlled production.
Bauer et al. (2001) — structures, solubility, seeding, and proposed trigger.
EMA (1998) — contemporaneous capsule-supply statement.
FDA NDA 20-945 chemistry review — regulatory and formulation record.
Morissette et al. (2003) — wider solid-form landscape and a Form-I recovery route.
Sacchi et al. (2024) — reproducible formation of Forms I and II under named milling conditions.

The JSON case records the full ten-source list, claim joins, access labels, and correction locators.